In Other News

• Multi-Biomarker Blood Test Detects Early-Stage Cancers Across Types

• New Sample-to-Answer PCR System Supports High-Throughput Infectious Disease Testing

• Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

• Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

• Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target

• Framework Guides Targeted Immunotherapy Selection in Liver Cancer

• Collaboration Brings Rapid At-Home STI Testing with Virtual Follow-Up

• AI Precision Tests Deliver Cancer Risk Insights from Routine H&E Slides

• mNGS CSF Test Identifies CNS Pathogens Missed by Standard Panels

• Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

• Study Reveals Moleclar Mechanism Driving Aggressive Skin Cancer

• Framework Guides Targeted and Immunotherapy Selection in Liver Cancer

• Collaboration Brings Rapid At-Home STI Testing with Virtual Follow-Up

• Study Reveals Moleclar Mechanism Driving Aggressive Skin Cancer

• Immune Aging Clock Quantifies Immune Age and Identifies T Cell Target

• Rapid Color Test Stratifies Virulent and Resistant Staph Strains

• Blood-Based Epigenetic Signals Enable Osteosarcoma Disease Monitoring

• Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk

• Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

• AI-Enabled Biochip Detects microRNA Biomarkers in Minutes

• QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026

• Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma

• Blood Test Detects Early Pancreatic Cancer in High-Risk Patients